Barclays
MDXH icon

Barclays’s MDxHealth MDXH Stock Holding History

Barclays’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.6K Buy
694
+310
+81% +$1.05K ﹤0.01% 4870
2025
Q4 		$1.37K Sell
384
-9,676
-96% -$38.2K ﹤0.01% 5071
2025
Q3 		$46.8K Buy
+10,060
New +$30.9K ﹤0.01% 4783
2023
Q1 		– Sell
-800
Closed -$5.29K – 5247
2022
Q4 		$5.29K Buy
+800
New +$5.68K ﹤0.01% 4994

Other funds holding MDXH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Barclays's MDXH Position: Q1 2026 in Review

Barclays increased its MDxHealth (MDXH) stake by 81% in Q1 2026, buying an estimated $1.05K and bringing the position to 694 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4870.

Barclays first reported a position in MDXH in Q4 2022 and has held it in 4 quarters since. The position peaked at $46.8K in Q3 2025. 51 funds tracked by Wall St. Rank hold MDXH as of Q1 2026.

  • Barclays held 694 shares of MDxHealth worth $1.6K as of Q1 2026.
  • Barclays bought 310 MDxHealth shares in Q1 2026, an estimated $1.05K.
  • MDxHealth made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4870 holding.
  • Barclays first reported a position in MDxHealth in Q4 2022 and has held it in 4 quarters since.
  • Barclays's MDxHealth position peaked at $46.8K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held MDxHealth as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.